美国安进地舒单抗注射液的价格多少

Xgeva is a recombinant human monoclonal antibody. Desosumab Xgeva inhibits osteoclast activity and reduces bone resorption and bone transformation by inhibiting RANKL. Since its launch in the United States in 2010, denosumab Xgeva has gradually become one of the important drugs for the treatment of malignant tumors and osteoporosis.

Instructions for use of Amgen's denosumab injection in the United States: Desomasumab Xgeva is simple and easy to use. Patients can subcutaneously inject 60 mg/time by themselves, with a 6-month interval between doses. While being treated with denosumab Xgeva, patients need to take 1000mg of calcium and at least 4001U of vitamin D per day. Patients should not increase or decrease the dose of the drug without authorization while receiving denosumab Xgeva. Increasing the dose of denosumab will not make the condition improve quickly, but will lead to adverse reactions. Only correct use of the drug will help the condition. Therefore, patients should strictly follow the doctor's instructions.

The original drug of denosumab Xgeva was developed by Amgen in the United States and is currently approved for multiple indications around the world. Amgen Biopharmaceutical Company (Amgen) is the world's leading innovative biopharmaceutical R&D and manufacturing company. It takes "drug innovation" as its core concept and attaches great importance to the accumulation of R&D capabilities. It has achieved major breakthroughs in the fields of human genome, tumor biology, neuroscience, hematology and other fields. How much does Amgen denosumab injection cost in the United States?

Desosumab Xgeva produced by Amgen Biopharmaceuticals in the United States is exported to China. Specification: 120mg/1.7ml bottle/box. Pharmacy price: RMB 5,298.00. Desosumab Xgeva produced by Amgen Biopharmaceuticals in the United States has the specifications in the United States: 60mg/1ml tube/box, price: US$1,169.98.  

Xgeva produced by Amgen Biopharmaceuticals in the United States is exported to Turkey in the form of 120 mg and sells for about $1,500. Since the exchange rate floating price is not fixed, if patients want to know the specific price information of denosumab Xgeva, they can consult the medical companion travel service.

Recommended related hot articles: /newsDetail/91045.html